CIM
Contravisory Investment Management Portfolio holdings
AUM
$508M
This Quarter Return
-0.89%
1 Year Return
+23.42%
3 Year Return
+97.74%
5 Year Return
+193.46%
10 Year Return
+427.78%
AUM
$460M
AUM Growth
+$460M
(-7.7%)
Cap. Flow
-$26M
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
32.51%
Holding
204
New
45
Increased
6
Reduced
49
Closed
33
Top Buys
| 1 |
HCA Healthcare
HCA
|
$11.7M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$11.6M |
| 3 |
CMS Energy
CMS
|
$8.82M |
| 4 |
McCormick & Company Non-Voting
MKC
|
$8.65M |
| 5 |
ANSS
Ansys
ANSS
|
$8.45M |
Top Sells
| 1 |
HSP
HOSPIRA INC
HSP
|
$19.8M |
| 2 |
Norfolk Southern
NSC
|
$11M |
| 3 |
Baidu
BIDU
|
$10.9M |
| 4 |
Entergy
ETR
|
$10.8M |
| 5 |
Applied Materials
AMAT
|
$9.67M |
Sector Composition
| 1 | Healthcare | 26.77% |
| 2 | Consumer Staples | 16.59% |
| 3 | Technology | 10.76% |
| 4 | Real Estate | 8.83% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $22M | 4.79% | 188,144 -15,183 | -7% | -$1.78M |
|
2
Humana
HUM
$36.5B
| $17.3M | 3.77% | 90,513 -9,690 | -10% | -$1.85M |
|
3
Moody's
MCO
$91.4B
| $17.1M | 3.71% | 157,983 -14,829 | -9% | -$1.6M |
|
4
Cintas
CTAS
$84.6B
| $15.3M | 3.33% | 180,731 -14,971 | -8% | -$1.27M |
|
5
CVS Health
CVS
$92.8B
| $15.2M | 3.3% | 144,670 -10,919 | -7% | -$1.15M |
|
6
Amgen
AMGN
$155B
| $14M | 3.05% | 91,390 -7,020 | -7% | -$1.08M |
|
7
Ashland
ASH
$2.57B
| $13.2M | 2.86% | 107,952 -8,427 | -7% | -$1.03M |
|
8
International Flavors & Fragrances
IFF
$17.3B
| $12M | 2.6% | 109,341 -7,153 | -6% | -$782K |
|
|
9
HCA Healthcare
HCA
$94.5B
| $11.7M | 2.56% | +129,505 | New | +$11.7M |
|
10
McKesson
MCK
$85.4B
| $11.7M | 2.54% | 51,957 -3,113 | -6% | -$700K |
|
|
BRCM
11
DELISTED
BROADCOM CORP CL-A
BRCM
| $11.6M | 2.53% | +226,030 | New | +$11.6M |
|
12
AB InBev
BUD
$122B
| $11.5M | 2.49% | 94,933 -5,940 | -6% | -$717K |
|
13
Check Point Software Technologies
CHKP
$20.7B
| $11.3M | 2.46% | 141,872 -10,551 | -7% | -$839K |
|
14
Equity Residential
EQR
$25.3B
| $10.9M | 2.38% | 155,819 -11,193 | -7% | -$785K |
|
15
Archer Daniels Midland
ADM
$30.1B
| $10.9M | 2.37% | 225,960 -16,392 | -7% | -$790K |
|
16
F5
FFIV
$18B
| $10.9M | 2.37% | 90,520 -5,211 | -5% | -$627K |
|
|
HDS
17
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.8M | 2.35% | 306,966 -25,768 | -8% | -$907K |
|
18
Boston Properties
BXP
$11.5B
| $10.6M | 2.31% | 87,892 -5,143 | -6% | -$622K |
|
19
TE Connectivity
TEL
$61B
| $10.6M | 2.31% | 165,008 -9,650 | -6% | -$620K |
|
20
3M
MMM
$82.8B
| $10.5M | 2.28% | 68,035 -4,141 | -6% | -$639K |
|
21
Bank of New York Mellon
BK
$74.5B
| $10.4M | 2.27% | 248,975 -13,525 | -5% | -$568K |
|
22
Merck
MRK
$210B
| $10.3M | 2.25% | 181,351 -9,607 | -5% | -$547K |
|
23
Ingredion
INGR
$8.31B
| $10.3M | 2.24% | 128,914 -9,383 | -7% | -$749K |
|
|
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
| $10.2M | 2.23% | 113,566 -8,466 | -7% | -$764K |
|
25
Johnson & Johnson
JNJ
$427B
| $10.1M | 2.2% | 103,567 -5,372 | -5% | -$524K |
|